Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Conditions:   Respiratory Tract Diseases;   Neoplasms;   Neoplasms by Histologic Type;   Neoplasms, Glandular and Epithelial;   Neoplasms, Squamous Cell;   Tumor Virus Infections;   Infections;   Virus Diseases;   DNA Virus Infections;   Pathologic Processes;   Disease Attributes;   Recurrence;   Papilloma;   Respiratory Tract Infections;   Papillomavirus Infections Intervention:   Drug: Bevacizumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials